{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:09:38Z","timestamp":1775142578407,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.esmoop.2022.100600","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T00:57:50Z","timestamp":1666054670000},"page":"100600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma"],"prefix":"10.1016","volume":"7","author":[{"given":"S.H.A.E.","family":"Derks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"de Joode","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.E.A.P.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.S.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Joosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.A.","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.J.","family":"Gr\u00fcnhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"van den Bent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0446-1907","authenticated-orcid":false,"given":"A.A.M.","family":"van der Veldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmoop.2022.100600_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100600_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2217\/fon-2018-0671","article-title":"Stage III melanoma incidence and impact of transitioning to the 8th AJCC staging system: a US population-based study","volume":"15","author":"Tarhini","year":"2019","journal-title":"Future Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100600_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clindermatol.2008.09.001","article-title":"Melanoma epidemiology and trends","volume":"27","author":"Garbe","year":"2009","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100600_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ejso.2019.01.225","article-title":"Stage-specific disease recurrence and survival in localized and regionally advanced cutaneous melanoma","volume":"45","author":"Leeneman","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"14","key":"10.1016\/j.esmoop.2022.100600_bib5","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System","volume":"22","author":"Barnholtz-Sloan","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100600_bib6","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1470-2045(21)00065-6","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial","volume":"22","author":"Eggermont","year":"2021","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.esmoop.2022.100600_bib7","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1708539","article-title":"Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma","volume":"377","author":"Long","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.esmoop.2022.100600_bib8","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1709030","article-title":"Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma","volume":"377","author":"Weber","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100600_bib9","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1245\/s10434-019-07274-2","article-title":"Early recurrence in completely resected IIIB and IIIC melanoma warrants restaging prior to adjuvant therapy","volume":"26","author":"Bloemendal","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100600_bib10","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/annonc\/mdz411","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Michielin","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2022.100600_bib11","series-title":"Melanoma: Cutaneous. Version 2","year":"2022"},{"key":"10.1016\/j.esmoop.2022.100600_bib12","series-title":"Melanoma: Assessment and Management","year":"2015"},{"key":"10.1016\/j.esmoop.2022.100600_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","article-title":"European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: update 2022","volume":"170","author":"Garbe","year":"2022","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100600_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-021-03813-8","article-title":"Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis","volume":"154","author":"Sandhu","year":"2021","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.esmoop.2022.100600_bib15","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ejca.2021.08.041","article-title":"Adjuvant treatment in patients with melanoma: the planning of scanning","volume":"157","author":"Mulder","year":"2021","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100600_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100600_bib18","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1093\/neuonc\/noab094","article-title":"Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)","volume":"23","author":"Tawbi","year":"2021","journal-title":"Neuro Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100600_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1470-2045(18)30139-6","article-title":"Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study","volume":"19","author":"Long","year":"2018","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100600_bib20","first-page":"769","article-title":"Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article","volume":"114","author":"Liew","year":"2011","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100600_bib21","first-page":"181","article-title":"Factors influencing the risk of local recurrence after resection of a single brain metastasis","volume":"113","author":"Patel","year":"2010","journal-title":"J\u00a0Neurosurg"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100600_bib22","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJMoa1805453","article-title":"Combined nivolumab and ipilimumab in melanoma metastatic to the brain","volume":"379","author":"Tawbi","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100600_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaad.2016.02.1229","article-title":"Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: a prospective cohort study","volume":"75","author":"Podlipnik","year":"2016","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100600_bib24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.annonc.2021.07.016","article-title":"EANO\u2013ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours","volume":"32","author":"Le Rhun","year":"2021","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100600_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043215","article-title":"Scanxiety: a scoping review about scan-associated anxiety","volume":"11","author":"Bui","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100600_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1017\/S0963180120000304","article-title":"The impact of incidental findings detected during brain imaging on research participants of the rotterdam study: an interview study","volume":"29","author":"Bomhof","year":"2020","journal-title":"Camb Q Healthc Ethics"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922002307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922002307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T09:24:56Z","timestamp":1718789096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922002307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2059702922002307"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100600","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The meaning of screening: detection of brain metastasis in the adjuvant setting for stage III melanoma","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100600"}}